Recent studies have pointed out the causal role of IDH1 mutations in Glioblastoma-CIMP [17, 19] and tight associations between IDH2 and TET2 mutations with other CIMPs (leukemia [26], enchondroma, and spindle cell hemangioma [27, 28]). Here, IDH2 is linked to glioblastoma.